Validation of the Psoriatic Arthritis Impact of Disease (PsAID) Questionnaire and its potential as a single-item outcome measure in clinical practice

…, C Cavill, N Waldron, M Brooke… - Annals of the …, 2018 - ard.bmj.com
Objectives The Psoriatic Arthritis Impact of Disease (PsAID) Questionnaire is a recently
developed patient-reported outcome measure (PROM) of disease impact in psoriatic arthritis (PsA…

Patient involvement in outcome measures for psoriatic arthritis

W Tillett, A Adebajo, M Brooke, W Campbell… - Current rheumatology …, 2014 - Springer
Psoriatic arthritis (PsA) is a heterogeneous inflammatory arthritis with a varied clinical phenotype.
There has been considerable international collaboration over recent years to develop …

Outcomes of the 2019 GRAPPA workshop on continuous composite indices for the assessment of psoriatic arthritis and membership-recommended next steps

…, PJ Mease, DD Gladman, M Brooke… - The Journal of …, 2020 - jrheum.org
Objective. Improving the assessment of psoriatic arthritis (PsA) is a key purpose of the
Group for Research and Assessment of Psoriasis and PsA (GRAPPA). Herein, we report the …

Diagnosis and initial management in psoriatic arthritis: a qualitative study with patients

E Dures, C Bowen, M Brooke, J Lord… - … advances in practice, 2019 - academic.oup.com
Objectives PsA is an inflammatory condition that can cause pain, fatigue, swelling and joint
stiffness. The consequences include impaired physical function, a high psychosocial burden, …

Haloperidol for psychosis‐induced aggression or agitation (rapid tranquillisation)

EG Ostinelli, MJ Brooke‐Powney, X Li… - Cochrane Database …, 2017 - cochranelibrary.com
Background Haloperidol used alone is recommended to help calm situations of aggression
or agitation for people with psychosis. It is widely accessible and may be the only …

A multicenter nominal group study to rank outcomes important to patients, and their representation in existing composite outcome measures for psoriatic arthritis

…, PS Helliwell, O FitzGerald, M Brooke… - The Journal of …, 2017 - jrheum.org
Objective. To rank outcomes identified as important to patients with psoriatic arthritis (PsA)
and examine their representation in existing composite measures. Methods. Seven nominal …

A survey of student nurses' and midwives' experiences of learning to use electronic health record systems in practice

…, S Chadwick, R Mann, M Brooke-Read - Nurse Education in …, 2013 - Elsevier
… panel Lesley Baillie a b , Sandra Chadwick c , Robert Mann c , Melanie Brooke-Read c …
between EHRs and the concept of ‘normality’ in childbirth (Brooke-Read et al., 2012)’. …

[HTML][HTML] Patients' perspectives of telemedicine appointments for psoriatic arthritis during the COVID-19 pandemic: results of a patient-driven pilot survey

H Jethwa, M Brooke, A Parkinson, E Dures… - Bmc Rheumatology, 2022 - Springer
Background Over recent years the lack of patient involvement in the design, set-up and
implementation of clinical research studies has been well recognised; as such there has been a …

Development of a flare instrument for use in psoriatic disease: a report from the 2015 GRAPPA annual meeting

…, A Parkinson, W Campbell, M Brooke… - The Journal of …, 2016 - jrheum.org
Objective. The objective of this Group for Research and Assessment of Psoriasis and Psoriatic
Arthritis (GRAPPA) initiative is to develop a questionnaire to determine the presence of a …

Effectiveness of Sequential Lines of Biologic and Targeted Small Molecule Drugs in Psoriatic Arthritis: A Systematic Review

…, R Vincent, C Fahy, N McHugh, M Brooke… - …, 2024 - academic.oup.com
Objective To assess current evidence for effectiveness of sequential lines of biologic and
targeted small molecule disease modifying anti-rheumatic drugs (b/tsDMARDs) when used …